Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology
Journal of Genome Biotechnology and Genetics · 24.06.2026 · 1 (2) · 10
DOI: 10.3390/jgbg1020010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genome Biotechnology and Genetics, online erschienen am 24.06.2026. Verfasst von Javier Alejandro Delgado-Nungaray und 5 weiteren Autor:innen. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SECIHTI.
Abstract (Originalsprache)
CRISPR-Cas9 has transformed microbial biotechnology by enabling precise genome modifications; however, achieving high editing efficiency remains a challenge due to multiple determinants, including on-target specificity, off-target events, PAM sequence, sgRNA scaffold composition, and RNA secondary structure. Our review foresees how artificial intelligence (AI) can address those challenges by enabling automated identification as well as highly active guide RNA (gRNA) optimisation. We highlight the influence of a data-driven training strategy that is focused on high-quality, diverse, and accurately labelled microbial datasets—mainly, given the limitations of models derived from mammalian systems that are not directly transferable to microbial organisms. Moreover, we discuss the key role of FAIR (Findable, Accessible, Interoperable, and Reusable) data principles and centralised, curated CRISPR-Cas databases as foundational elements for developing robust and predictive frameworks. Emerging directions are also explored, including generative AI approaches capable of supporting automated experimental planning. By considering the potential dual use of such technologies, the review further addresses bioethical considerations and regulatory frameworks necessary to ensure responsible genome engineering as a milestone, as well as the implementation of safeguards against misuse, particularly in pathogenic microorganisms. Furthermore, the convergence of standardised experimental data, specialised microbial datasets, and advanced AI architectures is paving the way to transform microbial biotechnology by accelerating metabolic engineering and synthetic biology applications.
Förderung
- SECIHTI
Zitieren
APA
Delgado-Nungaray, J. A., Pérez-Ponce, D. A., Figueroa-Yáñez, L. J., Reynaga-Delgado, E., García-Ramírez, M. A., & Gonzalez-Reynoso, O. (2026). Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology. Journal of Genome Biotechnology and Genetics, 1(2), 10. https://doi.org/10.3390/jgbg1020010
Vancouver
Delgado-Nungaray JA, Pérez-Ponce DA, Figueroa-Yáñez LJ, Reynaga-Delgado E, García-Ramírez MA, Gonzalez-Reynoso O. Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology. Journal of Genome Biotechnology and Genetics. 2026;1(2):10. doi:10.3390/jgbg1020010
BibTeX
@article{DelgadoNungaray2026,
author = {Delgado-Nungaray, Javier Alejandro and Pérez-Ponce, Dulce Alitzel and Figueroa-Yáñez, Luis Joel and Reynaga-Delgado, Eire and García-Ramírez, Mario Alberto and Gonzalez-Reynoso, Orfil},
title = {Advances in AI-Guided CRISPR-Cas9 Engineering Strategies for Microbial Biotechnology},
journal = {Journal of Genome Biotechnology and Genetics},
year = {2026},
volume = {1},
number = {2},
pages = {10},
doi = {10.3390/jgbg1020010}
}
EUVIMED